ResearcherShandong Tumor HospitalActive in the last 2 years

Yubo Jiang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5110575129. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 2 papers

Papers 2

PUS7 promotes the progression of pancreatic cancer by interacting ANLN to activate MYC pathway. Co-author DOI 10.1007/s11010-025-05267-2 ↗
Molecular characterization and prognostic implications of KRAS mutations in pancreatic cancer patients: insights from multi-cohort analysis. Co-author DOI 10.1038/s41698-025-01087-1 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jingtao Zhong · 1 shared paper, 2025 · strength 0.37
- Paper PUS7 promotes the progression of pancreatic cancer by interacting ANLN to activate MYC pathway. DOI 10.1007/s11010-025-05267-2 ↗
Zuoxing Niu · 1 shared paper, 2025 · strength 0.21
- Paper Molecular characterization and prognostic implications of KRAS mutations in pancreatic cancer patients: insights from m… DOI 10.1038/s41698-025-01087-1 ↗
Huirong Xu · 1 shared paper, 2025 · strength 0.21
- Paper Molecular characterization and prognostic implications of KRAS mutations in pancreatic cancer patients: insights from m… DOI 10.1038/s41698-025-01087-1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.